Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A.
about
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disordersScreening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis.An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics.A systematic review of cost-effectiveness analyses of pharmacogenomic interventions.Economic analyses of human genetics services: a systematic review.Genetic testing in the European Union: does economic evaluation matter?Economic evaluation of using a genetic test to direct breast cancer chemoprevention in white women with a previous breast biopsy.
P2860
Q22330767-FCA620D1-4938-4FBF-BFAB-7324BFF9FAD8Q34452378-93E8EF1E-CE31-4393-8140-DB2F03E7309BQ35116075-2ECA2D40-08AF-49D3-8CE7-698A35C2F4B2Q35976416-60CCA8DF-B02E-47B9-BFC6-A0CC8A96E84BQ36296074-DB4D0C97-EC07-4782-B96C-0D8F27F423F4Q37877618-47575EEC-131C-470E-93A1-26561B0EB9A5Q50460101-2CDB7409-593C-4ECB-8276-73AF0D9324E2
P2860
Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@ast
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@en
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@nl
type
label
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@ast
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@en
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@nl
prefLabel
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@ast
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@en
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@nl
P2093
P356
P1476
Cost-effectiveness of screenin ...... eiden and prothrombin G20210A.
@en
P2093
P304
P356
10.1093/QJMED/94.7.365
P407
P577
2001-07-01T00:00:00Z